Related Experiment Video

Updated: Jun 13, 2026

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
07:21

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment

Published on: June 23, 2019

Impact of HIV on standard case management for severe pneumonia in children

Penny M Enarson1, Robert P Gie, Donald A Enarson

  • 1Child Lung Health Division, International Union Against Tuberculosis and Lung Disease (The Union), 68 Boulevard St Michel, 75006 Paris, France. penarson@theunion.org

Expert Review of Respiratory Medicine
|April 22, 2010
PubMed

Insights

Pneumonia is a major killer of young children in sub-Saharan Africa, especially those with HIV. HIV-infected children face a sixfold higher risk of death from pneumonia, necessitating urgent research into effective management strategies.

Area of Science:

  • Global Health
  • Pediatrics
  • Infectious Diseases

Background:

  • Pneumonia causes an estimated 2 million deaths annually in children under 5, with half occurring in sub-Saharan Africa.
  • Sub-Saharan Africa accounts for over 85% of the world's 2.3 million children living with HIV.
  • HIV infection significantly impacts pediatric pneumonia management and outcomes.

Purpose of the Study:

  • To review published studies on the impact of HIV on childhood pneumonia in sub-Saharan Africa.
  • To understand the increased fatality rates and causative pathogens in HIV-infected children with pneumonia.
  • To inform strategies for preventing and managing HIV-related pneumonia in the region.

Main Methods:

  • Systematic review of published literature on childhood pneumonia and HIV in sub-Saharan Africa.
  • Analysis of studies reporting pneumonia-related fatality rates in HIV-infected versus HIV-uninfected children.
  • Identification of common and opportunistic pathogens associated with pneumonia in HIV-infected children.

Main Results:

  • HIV-infected African infants and children experience a sixfold increased risk of pneumonia-related death (range 2.5-13.5-fold).
  • HIV-infected children are more susceptible to mixed infections and a broader spectrum of pathogens, including Pneumocystis pneumonia, TB, and cytomegalovirus.
  • Significant disparities in pneumonia outcomes exist between HIV-infected and uninfected children in sub-Saharan Africa.

Conclusions:

  • HIV infection dramatically increases pneumonia fatality rates in African children.
  • Preventing HIV and Pneumocystis pneumonia is crucial for reducing the burden of HIV-related pneumonia.
  • Further research is urgently needed to establish optimal pneumonia case management for HIV-infected children.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...